MDGL

Madrigal Pharmaceuticals, Inc.NASDAQHealthcare

$546.89+3.22%ClosedMarket Cap: $12.55B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-02-20	B of A Securities	—	Neutral	—
2026-01-20	Citizens	—	Market Outperform	—
2025-12-19	Piper Sandler	—	Overweight	—
2025-12-11	B. Riley Securities	—	Buy	—
2025-11-21	HC Wainwright & Co.	—	Buy	—
2025-11-20	Oppenheimer	—	Outperform	—
2025-11-19	Truist Securities	—	Buy	—
2025-11-13	Canaccord Genuity	—	Buy	—
2025-11-05	Citizens	—	Market Outperform	—
2025-11-05	Cantor Fitzgerald	—	Overweight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$12.87	$2.17B	9
Sun Dec 31	$31.37	$2.99B	11
Mon Dec 31	$49.53	$3.90B	4
Tue Dec 31	$70.33	$4.87B	4